Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2023 Filed Oct 11, 2023 16:03 UTC |
Bonini SheilaDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025734 · form4.xml · nonDerivative · entry 1 Bonini Sheila · CIK 0001973331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,520 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:04 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025735 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,346.7917 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:07 UTC |
Chang AmyDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025736 · form4.xml · nonDerivative · entry 1 Chang Amy · CIK 0001551504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,459.1852 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:08 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025737 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,583.6382 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:09 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025738 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,071.1821 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:10 UTC |
LEE DEBRA LDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025739 · form4.xml · nonDerivative · entry 1 LEE DEBRA L · CIK 0001119838 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,140.5628 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total Includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:11 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025740 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,428.7983 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:12 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025741 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,307.1324 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:14 UTC |
Portman Robert JonesDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025742 · form4.xml · nonDerivative · entry 1 Portman Robert Jones · CIK 0001973769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,616.2788 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:15 UTC |
Subramaniam RajeshDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025743 · form4.xml · nonDerivative · entry 1 Subramaniam Rajesh · CIK 0001679607 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,170.8653 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:16 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025744 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,380.2381 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 03, 2023 Filed Oct 4, 2023 19:53 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 1,517 | $145.15 | $220,192.55 |
DisclosureSEC source: 0001127602-23-025495 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,584.4543 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 18:01 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
SaleCommon Stock | 165 | $144.97 | $23,920.40 |
DisclosureSEC source: 0001127602-23-025058 · form4.xml · nonDerivative · entry 1 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 814.2947 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 20:11 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 575 | $144.97 | $83,358.96 |
DisclosureSEC source: 0001127602-23-025152 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,498.1923 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 20:09 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 2,769 | $144.97 | $401,427.74 |
DisclosureSEC source: 0001127602-23-025148 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,376.091 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 20:12 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 313 | $144.97 | $45,376.27 |
DisclosureSEC source: 0001127602-23-025155 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 5,997.443 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 20:12 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,413 | $144.97 | $204,845.58 |
DisclosureSEC source: 0001127602-23-025155 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,306.2241 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 20:14 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 1,599 | $144.97 | $231,810.39 |
DisclosureSEC source: 0001127602-23-025163 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,773.7906 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:09 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantStock Option (Right to Buy) · Derivative | 52,792 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025445 · form4.xml · derivative · entry 3 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,792 Underlying: Common Stock · 52,792 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:13 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantStock Option (Right to Buy) · Derivative | 59,252 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025451 · form4.xml · derivative · entry 4 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,252 Underlying: Common Stock · 59,252 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:15 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantStock Option (Right to Buy) · Derivative | 52,251 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025454 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,251 Underlying: Common Stock · 52,251 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:16 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantStock Option (Right to Buy) · Derivative | 44,666 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025456 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,666 Underlying: Common Stock · 44,666 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:19 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantStock Option (Right to Buy) · Derivative | 20,952 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025459 · form4.xml · derivative · entry 3 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,952 Underlying: Common Stock · 20,952 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:19 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantCommon Stock | 4,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025459 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,435.1923 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:21 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 92,079 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025462 · form4.xml · derivative · entry 6 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,079 Underlying: Common Stock · 92,079 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:22 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 163,695 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025466 · form4.xml · derivative · entry 4 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,695 Underlying: Common Stock · 163,695 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:22 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantCommon Stock | 16,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025466 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,907.091 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:25 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 8,770 | $145.19 Strike: $145.19 | $1,273,316.30 |
DisclosureSEC source: 0001127602-23-025467 · form4.xml · derivative · entry 3 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,770 Underlying: Common Stock · 8,770 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:27 UTC |
Schulten AndreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 41,107 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025468 · form4.xml · derivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,107 Underlying: Common Stock · 41,107 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:27 UTC |
Schulten AndreChief Financial Officer
|
GrantCommon Stock | 9,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025468 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,459.7906 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:28 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 55,131 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025469 · form4.xml · derivative · entry 6 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,131 Underlying: Common Stock · 55,131 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:28 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 12,168 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025469 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 12,168 Underlying: Common Stock · 12,168 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:30 UTC |
Coombe Gary ACEO - Grooming
|
GrantStock Option (Right to Buy) · Derivative | 54,590 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025471 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,590 Underlying: Common Stock · 54,590 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:31 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 38,878 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025472 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,878 Underlying: Common Stock · 38,878 shares Expires 2033-09-30 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 19:53 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 27,215 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025495 · form4.xml · derivative · entry 3 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,215 Underlying: Common Stock · 27,215 shares Expires 2033-09-30 Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 17:32 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 8,938 | $153.47 Strike: $153.47 | $1,371,714.86 |
DisclosureSEC source: 0001127602-23-024391 · form4.xml · derivative · entry 3 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,938 Underlying: Common Stock · 8,938 shares Expires 2033-09-15 Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 17:33 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 8,571 | $153.47 Strike: $153.47 | $1,315,391.37 |
DisclosureSEC source: 0001127602-23-024392 · form4.xml · derivative · entry 6 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 8,571 Underlying: Common Stock · 8,571 shares Expires 2033-09-15 Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 17:33 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 27,747 | $153.47 Strike: $153.47 | $4,258,332.09 |
DisclosureSEC source: 0001127602-23-024392 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,747 Underlying: Common Stock · 27,747 shares Expires 2033-09-15 Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 17:35 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 13,240 | $153.47 Strike: $153.47 | $2,031,942.80 |
DisclosureSEC source: 0001127602-23-024393 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,240 Underlying: Common Stock · 13,240 shares Expires 2033-09-15 Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 15:45 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 198 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-024033 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,338.3598 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 15:47 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 231 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-024035 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,826.7917 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 15:49 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 296 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-024036 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,063.6382 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 15:50 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 198 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-024037 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,551.1821 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 15:51 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 239 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-024038 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,908.7983 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 15:52 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 198 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-024039 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,787.1324 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 15:53 UTC |
Portman Robert JonesDirector
|
GrantCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-024040 · form4.xml · nonDerivative · entry 1 Portman Robert Jones · CIK 0001973769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96.2788 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 15:55 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-024041 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,860.2381 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| August 30, 2023 Filed Aug 31, 2023 19:18 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 5,309 | $153.90 | $817,056.69 |
DisclosureSEC source: 0001127602-23-023469 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,719.2241 F1 · price: Weighted average price of the shares sold. The price range was $153.9001 to $153.91. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 30, 2023 Filed Aug 31, 2023 19:19 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 10,094 | $154.00 | $1,554,476.00 |
DisclosureSEC source: 0001127602-23-023470 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,895.5349 Read SEC document |
| August 30, 2023 Filed Aug 31, 2023 19:20 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 11,522 | $154.13 | $1,775,926.19 |
DisclosureSEC source: 0001127602-23-023471 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,135.1522 F1 · price: Weighted average price of the shares sold. The price range was $154.120 to $154.165. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.